Vertex Pharmaceuticals
Price & Volume
Stats
See more52W Range | $362.50-$519.68 |
Market Cap | $110.8B |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $11.7B |
Revenue Growth (YoY) | 11% |
Gross Profit (12 Mos) | $6.1B |
Diluted EPS | $14.22 |
News
See moreYahoo Finance • 5 days ago
Validea Detailed Fundamental Analysis - VRTX
Yahoo Finance • 6 days ago
2 Healthcare Stocks For Beginner Investors With a 30-Year Time Horizon
Yahoo Finance • 11 days ago
Stifel Maintains Hold Rating on Vertex (VRTX), Keeps $445 Price Target
Yahoo Finance • 12 days ago
1 Incredible Reason to Buy Vertex Pharmaceuticals Stock in November
About
CEO | Dr. Reshma Kewalramani FASN, M.D. |
CFO | Mr. Charles F. Wagner Jr. |
Address | 50 Northern Avenue, Boston, MA, United States, 02210 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 6,100 |
